testosterone undecanoate

Chemical data

Formula

C30H48O3

Molecular weight

456.7 g/mol

IUPAC name

[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate

via PubChem

Drug data · ChEMBL

Max clinical phase

Approved

Molecule type

Small molecule

First approval

2014

Admin. routes

oral, parenteral

Indications

sexual dysfunction, renal cell carcinoma, coronary artery disease, respiratory failure

via ChEMBL · EBI

• Testosterone Undecanoate-Schering AG.Drugs in R&D · 2004
• Testosterone undecanoate in the treatment of male hypogonadism.Expert opinion on pharmacotherapy · 2010
• Newer formulations of oral testosterone undecanoate: development and liver side effects.Sexual medicine reviews · 2025
• Injectable testosterone undecanoate for the treatment of hypogonadism.Expert opinion on pharmacotherapy · 2014
• Testosterone undecanoate administration prevents declines in fat-free mass but not physical performance during simulated multi-stressor military operations.Journal of applied physiology (Bethesda, Md. : 1985) · 2022

via PubMed